Quest Diagnostics

AI Score

0

Unlock

162.28
-0.36 (-0.22%)
At close: Feb 10, 2025, 10:19 AM
undefined%
Bid 162.06
Market Cap 18.11B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 7.69
PE Ratio (ttm) 21.1
Forward PE n/a
Analyst Hold
Ask 162.33
Volume 73,646
Avg. Volume (20D) 903,361
Open 162.34
Previous Close 162.64
Day's Range 161.72 - 163.35
52-Week Range 123.30 - 167.08
Beta undefined

About DGX

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPat...

Sector Healthcare
IPO Date Dec 17, 1996
Employees 50,000
Stock Exchange NYSE
Ticker Symbol DGX

Analyst Forecast

According to 13 analyst ratings, the average rating for DGX stock is "Hold." The 12-month stock price forecast is $180, which is an increase of 10.92% from the latest price.

Buy 53.85%
Hold 46.15%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Quest Diagnostics is scheduled to release its earnings on Apr 22, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+5.62%
Quest Diagnostics shares are trading higher follow... Unlock content with Pro Subscription
3 months ago
+6.85%
Quest Diagnostics shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 revenue guidance above estimates.